[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vita Coco (COCO) Executive Chairman and Director Michael Kirban reported open‑market sales made under a Rule 10b5‑1 trading plan. He sold 30,000 shares at $45.701 on 10/29/2025 and 14,898 shares at a weighted average price of $44.211 on 10/30/2025.

The 10/30 transactions occurred in multiple trades between $44.00 and $45.00. Following the reported sales, beneficial ownership reported included 1,484,151 shares held indirectly by the Michael Kirban 2010 Trust, plus 127,629 shares held directly and 615,681 shares held indirectly by the Michael Kirban Revocable Trust.

Reported derivative holdings include non‑qualified stock options to purchase 546,000 shares at $10.178 expiring 12/16/2029 (fully vested), 298,507 shares at $15 expiring 10/21/2031, and 70,715 shares at $32.78 expiring 03/03/2035, among others, with specified vesting schedules.

Insights

Corporate governance analyst

Routine insider sales under a 10b5‑1 plan; neutral impact.

Michael Kirban, Executive Chairman of Vita Coco, disclosed sales of 30,000 shares at $45.701 on 10/29/2025 and 14,898 shares at a weighted average $44.211 on 10/30/2025, executed pursuant to a Rule 10b5‑1 plan. The 10/30 trades spanned $44.00–$45.00.

Post‑transaction, the filing lists 1,484,151 shares indirectly via the 2010 Trust, plus 127,629 direct and 615,681 via the Revocable Trust. Derivative positions include options such as 546,000 at $10.178 expiring 12/16/2029 and 298,507 at $15 expiring 10/21/2031.

These are administrative disclosures typical for Form 4. Actual market impact depends on holder activity and trading volumes; the presence of a 10b5‑1 plan indicates pre‑established trading instructions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/29/2025		S(1)		30,000	D	$45.701	1,499,049	I	by M. Kirban 2010(2)
Common Stock	10/30/2025		S(1)		14,898	D	$44.211(3)	1,484,151	I	by M. Kirban 2010(2)
Common Stock								127,629	D
Common Stock								615,681	I	by M. Kirban Revoc(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(5)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (right to buy)	$10.178							(6)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(7)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(10)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. These shares are held by the Michael Kirban 2010 Trust.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $45.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. These shares are held by the Michael Kirban Revocable Trust.

5. The stock option is fully vested and currently exercisable.

6. The stock option is fully vested and currently exercisable.

7. The stock option vests in four equal annual installments beginning on November 27, 2022.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Michael Kirban	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who from Vita Coco (COCO) reported transactions on Form 4?

Executive Chairman and Director Michael Kirban reported the transactions.

How many Vita Coco shares did Michael Kirban sell and on what dates?

He sold 30,000 shares on 10/29/2025 at $45.701 and 14,898 shares on 10/30/2025 at a weighted average $44.211.

Were the COCO share sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5‑1 trading plan.

What price range applied to the 10/30/2025 COCO sales?

The $44.211 weighted average reflects multiple trades between $44.00 and $45.00.

What COCO shares did Michael Kirban report owning after the transactions?

Reported holdings included 1,484,151 shares indirectly via the Michael Kirban 2010 Trust, 127,629 shares directly, and 615,681 shares via the Michael Kirban Revocable Trust.

What stock options were disclosed for Michael Kirban?

Options included 546,000 at $10.178 expiring 12/16/2029, 298,507 at $15 expiring 10/21/2031, and 70,715 at $32.78 expiring 03/03/2035, with noted vesting schedules.